Onsite coronavirus test – for business and professional use only

The AlphaBiolabs IgM-IgG Combined Antibody Rapid Test is one of the world’s first rapid screening tests for the identification of coronavirus infection from 21 days after exposure to the virus or 7 days onwards after the onset of symptoms. This accurate screening test is used widely in Germany to identify a body’s response to COVID-19 infections and has been deemed ‘fit for use’ from the NHS. Please see the attached letter here.

During an extensive review of the technical data of the current COVID-19 immunoassay devices available, our scientific team deemed our COVID-19 screening devices as the most accurate. Additionally, the reliability and accuracy of our COVID-19 antibody screening kits has been verified during a recent NHS evaluation.

The single-use antibody test detects both early and late marker IgM/IgG antibodies in human finger-prick blood samples, therefore highlighting a recent infection that may still be active (IgM) or a previous infection (IgG).

If you need to detect an active COVID-19 infection using throat/nasal swabs, click here for our rapid rt PCR testing.